Eurasian medicines common market debuts

At the end of April 2018, the Eurasian Economic Union (EAEU) common market, regulating the circulation of medicines in the Union, was officially presented in Brussels within the framework of the international conference “Regional pharmaceutical markets of the European Union and the Eurasian Economic Union – trends, challenges and best regulatory practices.”

The event was organized by the European Federation of Pharmaceutical Industries and Associations (EFPIA), the Association of International Pharmaceutical Manufacturers (AIPM) with the support of the Eurasian Economic Commission (EEC) and the Eurasian Communication Center (ECC).

Over the last few years, this format of meetings has become traditional for the European Union and the EAEU regulatory authorities and expert organizations, as well as for representatives of the pharmaceutical industry. A discussion platform was created allowing in the form of the open and professional dialogue for sharing of experience and consideration of contemporary tendencies in regulation of medicines within the framework of regional integration, convergence of regulatory requirements towards manufacturing and quality control of medicines, pharmacovigilance, marketing authorization procedures, inspections and intellectual property protection, among many other questions.